Contrast-enhanced mammography for the assessment of screening recalls: a two-centre study.

ABSTRACT:

Objectives

To evaluate the potential of contrast-enhanced mammography (CEM) for reducing the biopsy rate of screening recalls.

Methods

Recalled women were prospectively enrolled to undergo CEM alongside standard assessment (SA) through additional views, tomosynthesis, and/or ultrasound. Exclusion criteria were symptoms, implants, allergy to contrast agents, renal failure, and pregnancy. SA and CEM were independently evaluated by one of six radiologists, who recommended biopsy or 2-year follow-up. Biopsy rates according to SA or recombined CEM (rCEM) were compared with the McNemar's test. Diagnostic performance was calculated considering lesions with available final histopathology.

Results

Between January 2019 and July 2021, 220 women were enrolled, 207 of them (median

SUBMITTER: Cozzi A 

PROVIDER: S-EPMC9668944 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature